Arkansas Man Sentenced to Prison for Developing and Distributing Prolific Malware

Washington, DC - An Arkansas man was sentenced today to 33 months in prison for aiding and abetting computer intrusions by selling malicious software, or “malware,” to individuals who used the malware to steal sensitive information, surreptitiously activate webcams, and conduct other illegal intrusions.

Leader of Guatemalan Drug Trafficking Organization Sentenced to Life in Prison

Washington, DC - Eliu Elixander Lorenzana-Cordon, 46, previously residing in La Reforma, Guatemala, was sentenced to life in prison following a trial in March 2016, where he was found guilty of conspiring to illegally import into the United States and distribute multi-ton quantities of cocaine.

Vice President Pence at the National Governors Association Luncheon

Washington, DC - Remarks by Vice President Pence at the National Governors Association Luncheon:

Justice Department Coordinates Nationwide Elder Fraud Sweep of More Than 250 Defendants

Washington, DC - Attorney General Jeff Sessions and law enforcement partners announced Thursday the largest coordinated sweep of elder fraud cases in history.   The cases involve more than two hundred and fifty defendants from around the globe who victimized more than a million Americans, most of whom were elderly.  The cases include criminal, civil, and forfeiture actions across more than 50 federal districts.  Of the defendants, 200 were charged criminally.  In each case, offenders engaged in financial schemes that targeted or largely affected seniors.  In total, the charged elder fraud schemes caused losses of more than half a billion dollars.  

NIH launches international study of AMD progression

Washington, DC - A new clinical study led by the National Eye Institute (NEI), part of the National Institutes of Health, will follow 500 people over five years to learn more about the natural history of early age-related macular degeneration (AMD). By using the latest technologies to visualize structures within the eye and measure their function, researchers hope to identify biomarkers of disease progression, well before it advances to late-stage disease and causes vision loss. AMD is the leading cause of vision impairment and blindness among people age 50 and older in the United States.